nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers
|
Beadle, G. |
|
|
20 |
1 |
p. 103-109 |
artikel |
2 |
Adjuvant chemotherapy and prognosis in patients with breast cancer
|
Kilickap, S. |
|
|
20 |
1 |
p. 192-193 |
artikel |
3 |
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
|
Schaich, M. |
|
|
20 |
1 |
p. 175-181 |
artikel |
4 |
A systematic review of the scales used for the measurement of cancer-related fatigue (CRF)
|
Minton, O. |
|
|
20 |
1 |
p. 17-25 |
artikel |
5 |
Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients
|
Boveri, E. |
|
|
20 |
1 |
p. 129-136 |
artikel |
6 |
Childhood cancer in Japan: focusing on trend in mortality from 1970 to 2006
|
Yang, L. |
|
|
20 |
1 |
p. 166-174 |
artikel |
7 |
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
|
Olmos, D. |
|
|
20 |
1 |
p. 27-33 |
artikel |
8 |
Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan
|
Ripamonti, C.I. |
|
|
20 |
1 |
p. 137-145 |
artikel |
9 |
Dietary intake of selected micronutrients and gastric cancer risk: an Italian case-control study
|
Pelucchi, C. |
|
|
20 |
1 |
p. 160-165 |
artikel |
10 |
Editorial Board
|
|
|
|
20 |
1 |
p. iii-iv |
artikel |
11 |
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone
|
Kim, B.-S. |
|
|
20 |
1 |
p. 121-128 |
artikel |
12 |
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study
|
De Ruysscher, D. |
|
|
20 |
1 |
p. 98-102 |
artikel |
13 |
Epidemiology of biliary tract cancers: an update
|
Randi, G. |
|
|
20 |
1 |
p. 146-159 |
artikel |
14 |
ESMO's new strategic plan: our society's road to the future of oncology
|
Baselga, J. |
|
|
20 |
1 |
p. 3-4 |
artikel |
15 |
Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases
|
Benlloch, S. |
|
|
20 |
1 |
p. 91-97 |
artikel |
16 |
Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer
|
Sigmond, J. |
|
|
20 |
1 |
p. 182-187 |
artikel |
17 |
Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer
|
Nakamura, K. |
|
|
20 |
1 |
p. 63-70 |
artikel |
18 |
instructions to authors
|
|
|
|
20 |
1 |
p. 195-197 |
artikel |
19 |
in this issue
|
|
|
|
20 |
1 |
p. 1 |
artikel |
20 |
Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?
|
Dizdar, O. |
|
|
20 |
1 |
p. 189 |
artikel |
21 |
L-Asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature
|
Jaccard, A. |
|
|
20 |
1 |
p. 110-116 |
artikel |
22 |
Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM Greek substudy
|
Markopoulos, C. |
|
|
20 |
1 |
p. 49-55 |
artikel |
23 |
Pharmacokinetics of sunitinib in hemodialysis
|
Izzedine, H. |
|
|
20 |
1 |
p. 190-192 |
artikel |
24 |
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
|
Perrone, F. |
|
|
20 |
1 |
p. 84-90 |
artikel |
25 |
Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer
|
Jenkins, P. |
|
|
20 |
1 |
p. 34-40 |
artikel |
26 |
Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study
|
Gobardhan, P.D. |
|
|
20 |
1 |
p. 41-48 |
artikel |
27 |
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients
|
Vincenzi, B. |
|
|
20 |
1 |
p. 78-83 |
artikel |
28 |
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
|
Dimopoulos, M.A. |
|
|
20 |
1 |
p. 117-120 |
artikel |
29 |
Reply to Adjuvant chemotherapy and prognosis in patients with breast cancer
|
Chamorey, E. |
|
|
20 |
1 |
p. 193-194 |
artikel |
30 |
Reply to Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?
|
Chamorey, E. |
|
|
20 |
1 |
p. 189-190 |
artikel |
31 |
Serum YKL-40 as a marker for cervical adenocarcinoma
|
Mitsuhashi, A. |
|
|
20 |
1 |
p. 71-77 |
artikel |
32 |
Table of Contents
|
|
|
|
20 |
1 |
p. v-vi |
artikel |
33 |
Title Page
|
|
|
|
20 |
1 |
p. ii |
artikel |
34 |
Trastuzumab treatment beyond brain progression in HER2- positive metastatic breast cancer
|
Kilickap, S. |
|
|
20 |
1 |
p. 192 |
artikel |
35 |
Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer
|
Park, I.H. |
|
|
20 |
1 |
p. 56-62 |
artikel |
36 |
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations
|
Papamichael, D. |
|
|
20 |
1 |
p. 5-16 |
artikel |